The start-up disrupting the field of women’s reproductive health
Drug Discovery World
AUGUST 17, 2023
DDW’s Diana Spencer speaks to Alok Javali , CSO of dawn-bio, a new addition to BioInnovation Institute’s (BII) Venture Lab acceleration programme, about the lack of innovation in women’s reproductive health and the company’s plans to fill the vacuum. Earlier this year, dawn-bio was one of five drug discovery companies to enter the BioInnovation Institute’s (BII) Venture Lab acceleration programme for early-stage companies.
Let's personalize your content